Related Articles
Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinib‑associated leukocytoclastic vasculitis: A case report
Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non‑small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case report
Killip classification and baseline heart rate can be used to predict streptokinase‑induced hypotension in acute myocardial infarction
Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS
Combination of Huanglian Jiedu Decoction and erlotinib delays growth and improves sensitivity of EGFR‑mutated NSCLC cells in vitro and in vivo via STAT3/Bcl‑2 signaling